Medication info
Olprez 10 mg (Olmesartan Medoxomil)

Olprez 10 mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›10mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201100802 · Approved 2011.02.21 · Insurance code 657804630

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this drug to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
Child dose
<Children> Safety and efficacy in children have not been established.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication used for the treatment of essential hypertension effectively controls blood pressure and reduces the risk of cardiovascular diseases. It works by dilating blood vessels or reducing the workload on the heart to lower blood pressure. Maintaining consistent use can help stabilize blood pressure and prevent complications such as stroke and myocardial infarction. Along with medication, it is important to improve lifestyle habits, and continuing medication under a doctor's guidance is advisable. It is used for the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this drug to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.

Child dose

<Children> Safety and efficacy in children have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be used by individuals with allergies to any component, pregnant or breastfeeding women, patients undergoing renal dialysis, patients with severe liver dysfunction, biliary obstruction, or certain genetically predisposed individuals with lactose intolerance. Patients with low blood volume or sodium may experience hypotension upon initial dosing, requiring careful observation, and if hypotension occurs, immediate appropriate action should be taken. Patients with weakened kidney function or kidney transplant recipients should have their potassium and creatinine levels checked regularly, and it is not recommended for patients with severe renal impairment. The effectiveness may be limited or there is a risk of side effects for some patients with heart diseases or primary aldosteronism, so caution is warranted. Dizziness may occur during treatment, so caution should be exercised when engaging in dangerous activities such as climbing or driving. Mild side effects such as dizziness, headache, back pain, indigestion, and cough may occur, but it is generally safe to use. In cases of chronic diarrhea or significant weight loss, this may indicate gastrointestinal diseases related to this medication, so it should be discussed with healthcare providers. When used with other antihypertensives, potassium-sparing diuretics, lithium preparations, or non-steroidal anti-inflammatory drugs, side effects may be increased due to interactions, so consultation with a specialist is necessary. Serious side effects may occur during pregnancy, so if pregnancy is planned or if pregnant, consultation with a doctor is essential. In breastfeeding cases, as the medication can pass into breast milk affecting the baby, it may be necessary to consider discontinuing breastfeeding or the medication. Safety in children has not been established, and caution is advised in pediatric usage. Elderly patients may have slower drug metabolism, so dosage adjustment and monitoring are necessary. Overdosage may lead to hypotension, palpitations, and bradycardia, requiring immediate appropriate medical treatment. This medication has been reported to have a low risk of carcinogenicity or genotoxicity even with long-term use, but if any abnormal symptoms occur, it should be reported to a specialist immediately.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • elevated creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • dyslipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • headache
  • hypertension
  • epistaxis
  • asthma
  • positional vertigo

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is important to maintain the storage temperature between 1 and 25 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.